Latest Breaking News On - Opaleye management - Page 2 : comparemela.com

Harrow, Inc (NASDAQ:HROW) Short Interest Update

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 5,500,000 shares, a decrease of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio […]

Craig hallumMarkl baumSurface ophthalmics incHarrow incOphir asset management pty ltdHarrow company profileHarrow health incEton pharmaceuticals incOpaleye management incSecurities exchange commissionPharmaceuticals incVanguard group incCapital managementGet free reportOpaleye managementExchange commission

TD Cowen Begins Coverage on Biodesix (NASDAQ:BDSX)

TD Cowen started coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a research report sent to investors on Monday, MarketBeat reports. The firm issued a buy rating and a $2.80 price objective on the stock. A number of other brokerages have also recently issued reports on BDSX. Lake Street Capital began coverage on […]

United statesOracle investment management incCanaccord genuity groupEssex investment management coBiodesix incBiodesix company profileOpaleye management incFree reportStreet capitalGenuity groupGet free reportInvestment managementOpaleye managementNodify lung nodule risk assessmentBiodesix daily

Syros Pharmaceuticals (NASDAQ:SYRS) Given Buy Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $15.00 target price on the stock. A number of other research analysts have also recently issued reports on the stock. StockNews.com cut shares of Syros Pharmaceuticals […]

Piper sandlerSyros pharmaceuticalsKennedy capital managementSyros pharmaceuticals incAcadian asset managementVanguard group incOpaleye management incNews ratings for syros pharmaceuticals dailySyros pharmaceuticals stock downInstitutional trading of syros pharmaceuticalsFree reportPharmaceuticals stock downGet free reportCapital managementAsset managementOpaleye management

Protara Therapeutics, Inc (NASDAQ:TARA) Short Interest Up 158 6% in April

Protara Therapeutics, Inc (NASDAQ:TARA) Short Interest Up 158 6% in April
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Protara therapeutics incOppenheimer coProtara therapeutics company profileExchange commissionOpaleye management incProtara therapeuticsGet free reportOpaleye managementFree reportProtara therapeutics daily

Jasper Therapeutics (NASDAQ:JSPR) Research Coverage Started at HC Wainwright

Jasper Therapeutics (NASDAQ:JSPR) Research Coverage Started at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Investment advisorsJasper therapeutics incRussell investments group ltdOpaleye management incFernwood investment managementRoyal bankJasper therapeuticsFree reportMarketbeat ratingsGet free reportInvestment managementInvestments groupOpaleye managementJasper therapeutics daily